A well-known pioneer in the industry of medical technologies and remote patient
monitoring services. As the founder of LifeWatch AG (former Card Guard AG and
Card Guard Scientific Survival Ltd.) he successfully led the company to an IPO. Up
until 2014, Dr. Geva was a member and the Chairman of the Board of Directors
and Corporate CEO of LifeWatch AG. During 1979 to 1989, Dr. Geva served as a
Chief Mechanical Engineer with Vishay Israel – a subsidiary of Vishay
Intertechnology, USA. Dr. Geva holds a B.Sc in Mechanical and Nuclear
Engineering, a Ph.D. (with honours) in Business Administration from the
International School of Management, Paris and an honorary doctorate from
Oxford Brooks University. Dr. Geva is also a senior member of the royal society of
medicine in the UK (RSM).
Dr. Kenneth Melani has over 30 years’ experience in the health care industry as a
provider, supplier and insurer. He began his career in 1981 as a practicing
physician growing his internal medicine practice into the largest multi-specialty
physician practice in Western Pennsylvania. In the mid 1980’s he helped start a
physician hospital organisation, West Penn Cares, where he became the CEO. In
this role he prepared the Organisation for managed care risk sharing contracts
(known as ACO’s today). In addition, he started seven successful for-profit health
services businesses. In 1989 he joined Highmark Inc. (formerly known as Blue Cross
of Western Pennsylvania) where he spent the next 23 years of his career in a variety
of positions including Chief Medical Officer, President of Health Related Services,
and EVP, Strategy and New Business Development. In 2003, he was named the
President and CEO of Highmark Inc. During his nine and half year tenure he grew
the company into one of the largest and most diversified health care companies
in the United States, serving over 32 million individuals.
Mr. Antoniou has a bachelor’s degree in economics from the University of
Bridgeport. He is multi-lingual with native knowledge of European operations and
is culturally literate and comfortable operating in international environments. Mr.
Antoniou is considered an industry pioneer with history of innovative program
evolution and cutting-edge product launches. During his professional career, he
was always involved in building a business from inception. He cultivated and gained
know how on various channels of distribution, including telephone companies,
MVNOs, mass merchants, specialists, electronic/cellular chains, catalog houses,
automotive and Car Manufacturers, telematics and M2M programs, application and
solutions, distributors and fulfillment houses.
Dr. Gleitman is the Chairman of the Guangzhuo Israel Biotech Fund, Chairman of
the Board of Directors of Capital Point Group, a Board member and Chairman of
the audit and financial committees of Elbit Systems (NASDAQ, TLV traded),
Chairman of the YoYa Group, Senior Advisor to the World Bank (national policy for
innovation) and Senior Strategy Advisor to Serbia Innovation Fund.
Prior to holding the positions set out above, Dr. Gleitman was the Chief Scientist
and Director General of Israel’s Ministry of Industry and Trade, where he managed
all of the Israeli Government technological programs. In the course of his four-year
tenure, Dr. Gleitman was responsible for allocating over $1.5 billion in grants in the
framework of promoting research and development activities in the Israeli hightech
Dr. Gleitman also served as the CEO of Ampal Investment Group (NASDAQ:
AMPL), where he was responsible for the investment of over $200 million in hightech
ventures. During his tenure at Ampal, Dr. Gleitman led a $330 million joint
venture with Motorola Israel founding Mirs Communications Ltd., Israel’s fourth
largest cellular operator.
Dr. Gleitman holds a Ph.D. (with distinction), M.Sc. (with distinction) and B.Sc. in
Physical Chemistry, from the Hebrew University of Jerusalem.
Dr. de Kauwe studied a Bachelor of Science in Pharmacology and Physiology and
Bachelor of Dental Surgery from the University of Western Australia. He also holds
a Post Graduate Diploma in Applied Finance, majoring in Corporate Finance, and
is an ASIC complaint (RG146) Securities Advisor. Dr. de Kauwe is a Director of
Otsana Capital, a corporate advisory firm with vast experience in corporate
restructuring and recapitalisations, mergers and acquisitions, IPO/RTO
transactions and capital markets. Dr. de Kauwe’s corporate experience, coupled
with his extensive technology, science and bio-medical background gives him an
integral understanding in the evaluation and execution of projects and assets
over a diverse range of sectors. He has held numerous ASX listed roles, particularly
in the Life Sciences and Technology sectors. He is currently a Director of Race
Oncology Ltd (ASX:RAC) and Ookami Ltd (ASX:OOK).
Mr Skontos holds a Bachelor of Engineering (Electrical) from the University of NSW
and has embarked on a sales, marketing & executive management career
spanning 28 years. After spending 10 years of his early career within the Industrial
automation industry with Texas Instruments & Mitsubishi Electric, he migrated to
the ever-changing world of telecommunications. During this phase of his career,
Sam worked with industry giants like SingTel, Optus and Vodafone and gained
valuable experience in sales & general management. In 2000, Sam had the
pleasure to help launch Virgin Mobile in Australia as its founding Sales Director. In
2008, Sam was mandated to re-launch the presence of a multinational device
provider, Alcatel, across Australia, NZ, Pacific Islands & Asia with great success.
Sam has a passion for technology, financial & business management, strategy,
marketing, negotiation, people management and has a desire to create
differentiation through innovation.
Mr Wettstein, citizen of Switzerland, was an advisor and investor in numerous pre-
IPO investments since 1985 and was instrumental for several successful IPO’s in
Switzerland. He operated his own accounting, auditing and tax consultancy firm
in Zurich, Switzerland from 1983 to 2007. From 1976 to 1982, he was an auditor and
tax consultant with Coopers & Lybrand AG, Zurich. Urs Wettstein graduated as a
Certified Public Accountant. From 2001 to 2014 he served as non-executive Vice
Chairman of the Board of Directors of LifeWatch AG, a company listed on the
Swiss Stock Exchange.
Ashley is the CEO of The Krongold Group, a third-generation, family-run group of companies based in Melbourne, Australia with businesses spanning various industries globally including, Construction, Property Development, Property Investment, Finance, Technology, Venture Capital and Travel. Prior to Krongold Group, Ashley spent 15 years in the Investment Banking and Accounting industries. He was a founding member of Investec Bank Australia and opened its Melbourne office in Nov 2000, later leading the Bank’s Private Client Lending division. Before Investec, Ashley worked at William Buck Chartered Accountants, ANZ Corporate Finance (London) and ANZ Private Banker (Australia).
Ashley serves on the Boards and is a Director of various ASX listed companies, communal charities, foundations and organisations globally. He is also a member of YPO (Young Presidents’ Organization), the world’s premier peer network of chief executives and business leaders. Ashley has a Bachelor of Commerce / Business from Monash University in Melbourne, Australia.
Mr Heumann is a top operation and business executive with proven ability to drive
efficiency and business value. Mr. Heumann brings with him advanced skills in
strategic planning, international negotiations and business development. Mr.
Heumann is a results-oriented leader with extensive experience in directing
complex projects. His expertise in streamlining efficiencies demonstrated great
success in reducing costs to the value of millions of dollars in his past roles as COO
in the US. He has more than 20 years’ experience in Hi-Tech, mHealth, operations
and services industries, helped with building high performance teams, and
managed multi-billion dollar budgets. Mr. Heumann attained his business
management education from Bar-Ilan University, Israel.
Mr Ben-Efraim is an experienced, senior CFO of global companies with more than
20 years’ experience in the finance and accounting domain. Mr. Ben-Efraim has
served in Israeli high tech companies like DSPC Group (a NASDAQ-traded
company), where he held a number of positions, including Chief Accountant of
the group, and El-Op where he was Deputy Controller in charge of tax and
accounting. From 2003, Mr. Ben-Efraim served as the Corporate CFO in a global
medical devices manufacturer and services provider company, where amongst
other things, he was in charge, of the cash flow management, annual budget
approvals, financial reporting to the stock exchange and analysts corporate
presentations. Mr. Ben-Efraim holds a B.A in Economics and Accounting from Tel
Aviv University, and is a Certified Public Accountant (IL).
Mr Geva has more than 17 years’ of experience in the Hi-Tech and medical
device industry, and as the former CTO and Strategic Projects Manager at
Lifewatch Technologies, Nir brings with him a broad knowledge on products
definition and development, project management and manufacturing of
medical devices. Nir has a strong development and manufacturing global
network and a deep understanding of the business culture. Nir has also been
involved in projects in the fields of mobile apps and IoT and wrote over 15 patents
related to medical devices, remote patients monitoring and IoT. Nir holds a BSc.
In Mechanical Engineering from the Technion in Haifa and an Executive MBA from
Kellogg School of Management (Northwestern University in Chicago).
Mr Bogart has a track record of more than 20 years as an executive in the medical
device and healthcare services and has substantial experience in strategic
business development and managing and directing sales force teams. Mr. Bogart
is a subject matter expert in mHealth, wireless telemedicine, and remote
monitoring. As a sales leader in the medical device and healthcare services field,
Mr. Bogart has led sizeable organisations. He has developed and grown
businesses from concept to financial success and commercialisation, including
thorough IPOs and acquisitions.